August 21, 2014 — A lawsuit has been filed against Janssen Pharmaceuticals and Bayer alleging that the popular blood-thinner Xarelto (rivaroxaban) caused a 92 year-old man to bleed to death.
On August 25, he suffered a life-threatening bleeding event. This caused severe pain and suffering, emotional distress, and permanent injuries that contributed to his sudden death on December 6, 2013.
The lawsuit was filed on August 14, 2014 in the U.S. District Court for the Eastern District of New York. According to the complaint, Janssen and Bayer are responsible for his death because they failed to adequately test Xarelto before marketing it as safe and effective.
The complaint also accuses the drug-makers of failing to warn about Xarelto side effects, calling their actions “callous, reckless, willful, depraved indifference to health, safety, and welfare of the Plaintiff-decedent herein.”
This is not the first Xarelto lawsuit filed in federal court in New York. In July 2014, a lawsuit was filed on behalf of a 71 year-old woman from Texas who developed severe bleeding after taking Xarelto for only four months. Click here to read more.
Xarelto belongs to a new class of blood-thinning drugs that have no effective reversal agent. In comparison, warfarin can be reversed with a dose of Vitamin K. Not even dialysis can de-activate Xarelto because it binds so tightly to proteins in a patient’s bloodstream.